Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for postoperative agitation and plasma NGAL/melatonin in abdominal surgery
ChiCTR1800016059Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in postoperative delirium (POD) (3 arms), sponsored by Affiliated Hospital of Nantong University. Primary endpoint: Postoperative agitation. Started May 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR1800016059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016059.